Science Applications International Corporation provides technical, engineering, and mission and enterprise information technology (IT) services in the United States.
FAIL · Does not pass the screen
129.90 USD
At the last full screen 2026-09-11
Screened 2026-09-11 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Science Applications International Corporation holds its Accumulation at $129.90. The statistical read favours the sellers, held for 53 days.
As held on the ledger · 2026-09-11
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 53 days
Price at the screen
$129.90
Valuation
15.14 trailing · 11.31 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.30
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
50.15%
Below 33%
Interest-bearing debt is 50.1% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
19.33%
Below 49%
Money owed to the company is 19.3% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 18.6% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Hold. The average target sits +3% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Government IT contractor shows little spark
Picture a steady supplier keeping Pentagon systems running day after day. SAIC delivers exactly that, yet the opportunity rating sits at none. Low single-digit revenue growth and a 6 percent profit margin leave little room for meaningful expansion even when the shares sit below our calculated fair value.
The 10.5 times forward earnings multiple looks attractive next to 28 percent return on equity. Analysts cluster around a hold rating with a 125 dollar median target, just above the current 115.51 dollar price. Ethical screens clear without issue, yet the combination still fails to register as compelling.
Government budget cycles and modest civilian segment momentum create real downside if spending tightens. Thin margins offer scant cushion against any contract loss or cost overrun. Analysis, not advice.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SAIC trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-31Markup$127.58+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markup$127.58+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markup$127.58+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-28Markup$127.58+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-27Markup$127.58+0.8%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-26Markup$126.54+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-25Markup$126.54+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$126.54+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-12Markup$126.54+11.2%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108.
2026-07-18Markup$113.81+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (10 analysts) rates it hold, with a mean price target of $108.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
